Efficacy of Cranial Manual Therapy in the Treatment of Chronic Insomnia Disorder

Not Applicable

• Conditions: Sleep Initiation and Maintenance Disorders
• Interventions: Other: Placebo therapy; Other: Osteopathic Medicine

• Registration Number: NCT05257317
• Lead Sponsor: Escoles Universitaries Gimbernat

Brief Summary

Insomnia is the most prevalent sleep disorder in society. The first treatment of choice is pharmacology, although it can have secondary effects such as tolerance and dependence, or alter the structure of sleep; therefore, new pathways towards other adjuvant treatments are being established. OBJECTIVES: The main objective is "To assess the effectiveness of manual cranial therapy on the quantity and quality of sleep in patients with chronic insomnia." MATERIAL AND METHODS: A randomized clinical trial is designed, with two groups, intervention and placebo, to assess the effectiveness of manual therapy applied to the skull, in the severity of insomnia, and quantity and quality of sleep in patients with sleep disorder. chronic insomnia. Health professionals will be selected from the Department of Occupational Health, with characteristics of chronic insomnia described by the ICSD-III, who do not modify their usual medication regimen (if they take it) and without other pathologies related to sleep that may be causing the insomnia. insomnia Demographic data (age, sex, profession), clinical (BMI, history of previous and family insomnia pathologies, and taking medication for sleep and related disorders), sleep quality questionnaires (PSQI, COS, ISI) will be collected. , stress-insomnia relationship (FISRST-S), and quality of life (SF12), in addition to filling out a sleep diary (through the mobile App) and recording activity through actigraphy, hypnogram (Sleep ProfilerTM); before and after the intervention, and at one and three month follow-up. Each group will receive the offered intervention: cranial manual therapy (intervention) or cranial massage (placebo). The data will be coded and analyzed with the IBM SPSS® version 20 program (or similar)

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2022-01-24
• Status Verified: 2022-02
• Study Start: 2022-02
• Study First Submitted QC: 2022-02-16
• Last Update Submitted: 2022-02-16
• Study First Posted: 2022-02-25
• Last Update Posted: 2022-02-25
• Primary Completion: 2022-12
• Study Completion: 2023-09

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• Diagnosed with chronic insomnia disorder according to the criteria defined by the ICSD-III (International Classification of Sleep Disorders-3rd edition):

  • Problems initiating or maintaining sleep, associated with daytime consequences; and not attributable to environmental circumstances.
  • Insomnia lasting more than 3 months, with episodes of at least 3 times a week.

• Regarding the pharmacology or medication indicated for sleep:

  • They do not want to take the medication recommended by the doctor who is treating them.
  • Do not change their usual drug regimen, if they were already taking medication to sleep.
  • They are not taxed to take medication.

• Having ruled out other pathologies related to sleep through:

  • Respiratory polygraphy to rule out sleep-related respiratory pathologies (SAHS).
  • screening to rule out motor sleep disorders.
  • screening to rule out circadian sleep disorders.
  • screening to rule out serious psychiatric disorders (depression, anxiety, general psychopathology): BDI-II (Beck Depression Inventory), BAI (Beck Anxiety Inventory), SCL-90.

• Obtain a score greater than 7 points (clinical-subclinical insomnia).

Exclusion Criteria

• Obtain a score of less than 7 (clinically insignificant insomnia) in the ISI test (Insomnia Severity Index).
• The result of the respiratory polygraphy is positive, confirming a sleep-disordered breathing.
• The screening tests for the detection of motor sleep disorders, respiratory sleep disorders or circadian disorders are positive.
• The Screening detects serious psychiatric illnesses such as major depressive disorder or bipolar disorders is positive.
• Suffering or having suffered from any central neurological pathology, stroke, aneurysm...
• Having suffered skull fractures.
• Having undergone surgery in the last 6 months and that insomnia has started as a result of it.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Placebo	Placebo therapy	It consists of a light contact applied to the cranial vault (frontal and parietal bones) where circular movements will be induced.
Intervention	Osteopathic Medicine	It will consist of osteopathic manual therapy techniques applied to the occipital and temporal bones.

Primary Outcome Measures

Name	Time	Method
Insomnia Severity	18 weeks	With an "Insomnia Severity Index" (ISI). There are seven items. Each item is rated on a scale from 0 to 4 from less to more severe. The total score is the sum of each individual item and can range from 0 to 28 (28 = most severe insomnia).

Secondary Outcome Measures

Name	Time	Method
Sleep Quality	18 weeks	With a "Cuestionario del Sueño de Oviedo (COS)". It consists of 15 items, 13 of which are grouped into 3 scales: * Subjective sleep satisfaction (1 item): score from 1 to 7.; * Insomnia (9 items) The scoring range is from 9 to 45, higher score indicate greater severity.; * Hypersomnia (3 items): from 3 to 15 points, higher score indicate greater daytime disability.
Vulnerability to stress-related insomnia	9 weeks	With FORD INSOMNIA RESPONSE TO STRESS spanish (FIRST-S). It is a scale that assesses vulnerability to stress-related insomnia. It is a standardized questionnaire with high test-retest reliability, which has been validated as a predictive measure of sleep vulnerability using polysomnographically measured sleep. It is made up of nine items and requires the individual to rate between 1 (not at all common) and 4 (very common) the probability of having sleep disturbance in association with specific and common stressful events or periods of stress that occur during the day or at night .; The total score of the answers obtained is quantified. High scores are indicative of increased vulnerability to stress-related insomnia. The cut-off score to detect individuals with this vulnerability is 19 points or higher, indicating "high-FIRST sleep reactivity."
Quality of Life of patients with insomnia	18 weeks	With a 12-items Short-Form Health Survey (SF12). It consists of 12 items from the 8 dimensions of the SF-36 Physical Function (2), Social Function (1), Physical Role (2), Emotional Role (2), Mental Health (2), Vitality (1), Body Pain (1), General Health (1). The response options form Likert-type scales that assess intensity or frequency. The number of response options ranges from three to six, depending on the item.; For each of the 8 dimensions that it identifies, the items are coded, aggregated and transformed into a scale ranging from 0 (the worst state of health for that dimension) to 100 (the best state of health).
Quantity, latency and efficiency of sleep	18 weeks	With an "Actigraphy record"
Hypnogram-Polysomnography - Macro and microstructure of sleep	18 weeks	With a "WachPAt(R) device"
Heart Rate Variability	4 weeks	With a "Polar H10 band" and "EliteHRV" app

Trial Locations

Locations (1)

Escoles Universitaries Gimbernat; 🇪🇸 Sant Cugat Del Vallès, Barcelona, Spain